Almirall 9M 2026: net sales up 8.3% to €889.2M, EBITDA up 22.7%
FROM THE WIRE · FINANCE.YAHOO.COM
Almirall continues to deliver solid results at 9M 2026, growing its European Dermatology business 17.6% YoY, increasing total Net Sales by 8.3%, and EBITDA by 22.7% – reiterating full-year guidance Total Almirall Net Sales increased by 8.3% YoY to €889.2 MM, while EBITDA…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishSolid results with full-year guidance reiterated, which can support the shares of a mid-cap pharma company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Total net sales rose 8.3% to €889.2 million.
- 02EBITDA increased 22.7% to €221.7 million, a 24.9% margin.
- 03Ebglyss® net sales grew 75.0% to €132.1 million.
- 04Full-year guidance was reiterated.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets